related documents
- Alendronate in primary hyperparathyroidism: Efficacy in men and premenopausal women. Conferences
- Alendronate once weekly for the prevention and treatment of osteoporosis in Canadian adult cystic fibrosis patients. Conferences
- Carboxyl-terminal fragments of PTH inhibit rPTH(1-34) induced 1,25(OH)(2) vitamin D synthesis and renal CYP28B1 mRNA expression in parathyroidectornized rats. Conferences
- Effectiveness of bone mineral density for predicting osteoporotic fractures in a large clinical population. Conferences
- Fracture risk and site-discordance: The total hip dominates other sites. Conferences
- Greater number of osteoporotic sites and fracture risk: Regression to the minimum. Conferences
- Importance of the calcium/phosphorus ratio in the growth plate normalisation during vitamin D and calcium repletion in the rat. Conferences
- It could happen to me: Perceptions of future fracture risk in individuals with a history of fragility fracture. Conferences
- Low BMD is associated with fractures in patients with renal failure: A meta-analysis. Conferences
- Prognostic factors for first clinical fracture in patients with primary osteoporosis: Data from the Canadian database of osteoporosis and osteopenia (CANDOO). Conferences
- The association among risk factors for fracture and family physicians' beliefs that their patients are at high risk for a future fracture: Canadian quality circle (CQC) national project. Conferences
- The cost-effectiveness of calcium and Vitamin D or hormone replacement therapy in the prevention of osteoporotic fractures in Canadian postmenopausal women. Conferences
- The rate that family physicians prescribe calcium and Vitamin D to their patients with fractures following an educational intervention: Canadian Quality Circle (CQC) national project. Conferences
- The relationship among key risk factors for fracture and family physicians' beliefs that their patients have osteoporosis: Canadian quality circle (CQC) National Project. Conferences